This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Gerard Reach: Innovator in Implantable Glucose Sensors
Introduction
Gerard Reach is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical engineering, particularly in the development of implantable glucose sensors. His innovative work aims to improve the quality of life for individuals requiring continuous glucose monitoring.
Latest Patents
Gerard Reach holds a patent for an implantable glucose sensor. This invention includes implantable enzymatic sensors designed for biochemicals such as glucose. The sensors are characterized by their ideal size and geometry for long-term implantation, providing linear responses over relevant concentration ranges. The design features an elongated body that supports an indicating electrode section with an appropriate enzyme immobilized to create an enzymatic indicating surface. A permeable synthetic polymer membrane is applied over the sensor body to protect the enzyme and regulate the diffusion of analytes, ensuring the linearity of sensor response. The flexible design allows for implantation using a catheter, and an alternative version includes an internal indicating electrode body housed within an apertured, hollow needle for easy manipulation.
Career Highlights
Gerard Reach is affiliated with the University of Kansas, where he continues to advance research in the field of glucose monitoring technologies. His work has garnered attention for its potential impact on diabetes management and patient care.
Collaborations
Gerard has collaborated with notable colleagues, including Dilbir S. Bindra and Brian S. Hill, who have contributed to his research endeavors.
Conclusion
Gerard Reach's innovative work in implantable glucose sensors represents a significant advancement in medical technology. His contributions are poised to enhance the lives of individuals managing diabetes through improved monitoring solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
